ECSP066382A - Proceso de purificación - Google Patents

Proceso de purificación

Info

Publication number
ECSP066382A
ECSP066382A EC2006006382A ECSP066382A ECSP066382A EC SP066382 A ECSP066382 A EC SP066382A EC 2006006382 A EC2006006382 A EC 2006006382A EC SP066382 A ECSP066382 A EC SP066382A EC SP066382 A ECSP066382 A EC SP066382A
Authority
EC
Ecuador
Prior art keywords
purification process
terbinafine
addition salt
free base
distillation
Prior art date
Application number
EC2006006382A
Other languages
English (en)
Inventor
Ulrich Beutler
Gerhard Penn
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28686596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP066382(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP066382A publication Critical patent/ECSP066382A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82—Purification; Separation; Stabilisation; Use of additives
    • C07C209/84—Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Proceso de purificación para la preparación de la alilamina farmacéutica terbinafina de fórmula (I) en forma de base libre o en forma de sal de adición de ácido, mediante destilación de la terbinafina cruda en forma de base, preferiblemente por destilación de trayectoria corta, por ejemplo a una temperatura por encima de 100º C y presión reducida, por ejemplo a 0,2 mbar, y recuperación del producto purificado en forma de base libre o en forma de sal de adición.
EC2006006382A 2003-08-29 2006-02-17 Proceso de purificación ECSP066382A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0320312.2A GB0320312D0 (en) 2003-08-29 2003-08-29 Purification process

Publications (1)

Publication Number Publication Date
ECSP066382A true ECSP066382A (es) 2006-09-18

Family

ID=28686596

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006382A ECSP066382A (es) 2003-08-29 2006-02-17 Proceso de purificación

Country Status (25)

Country Link
US (2) US20060076227A1 (es)
EP (1) EP1694631A2 (es)
JP (1) JP5208416B2 (es)
KR (2) KR101233024B1 (es)
CN (1) CN100491334C (es)
AR (1) AR045506A1 (es)
AU (1) AU2004268051B2 (es)
BR (1) BRPI0413896A (es)
CA (1) CA2536498C (es)
EC (1) ECSP066382A (es)
GB (1) GB0320312D0 (es)
IL (1) IL173709A (es)
IS (1) IS8369A (es)
MA (1) MA28030A1 (es)
MX (1) MXPA06002348A (es)
MY (1) MY149357A (es)
NO (1) NO20061404L (es)
NZ (1) NZ545445A (es)
PE (1) PE20050873A1 (es)
RU (1) RU2367649C2 (es)
SG (1) SG145782A1 (es)
TN (1) TNSN06066A1 (es)
TW (1) TWI350829B (es)
WO (1) WO2005021483A2 (es)
ZA (1) ZA200601264B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0503942D0 (en) * 2005-02-25 2005-04-06 Novartis Ag Purification process
EP1900378A1 (en) * 2006-08-31 2008-03-19 Novartis AG Pharmaceutical compositions for the treatment of fungal infections
KR101267728B1 (ko) 2008-09-05 2013-05-24 테이코쿠 팔마 유에스에이, 인코포레이티드 이온 영동 약물 전달 시스템
WO2025235780A1 (en) 2024-05-10 2025-11-13 Astrotech Technologies, Inc. Chemical distillation system with in situ analytics

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862103D1 (en) * 1977-08-19 1982-11-18 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them
CY1410A (en) * 1979-08-22 1988-04-22 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
CS232849B1 (cs) * 1983-05-04 1985-02-14 Ladislav Kalvoda Způsob přípravy honjugavaných eninů
RU2005717C1 (ru) * 1989-02-17 1994-01-15 Такеда кемикал-индастриз Лтд Способ получения производных аралкиламинов или их кислотно-аддитивных солей
CH678527A5 (en) 1989-06-22 1991-09-30 Sandoz Ag Trans(E)-N-(1-naphthyl:methyl)-heptenyl-amine prepn. - by simultaneously converting crude mixt. contg. cis and trans isomers to salt and precipitating trans isomer
JP3116364B2 (ja) 1989-10-02 2000-12-11 萬有製薬株式会社 エンイン誘導体の製造法
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DK1222160T3 (da) 1999-10-22 2003-11-17 Richter Gedeon Vegyeszet Fremgangsmåde til fremstilling af substituerede allylaminderivater og salte deraf
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
ITMI20010421A1 (it) 2001-03-01 2002-09-02 Ausimont Spa Membrane porose semipermeabili di fluoropolimeri semicristallini
ITMI20010430A1 (it) * 2001-03-02 2002-09-02 Dinamite Dipharma S P A In For Metodo per la sintesi di terbinafina
KR100459275B1 (ko) 2001-12-28 2004-12-03 주식회사유한양행 터비나핀 또는 그의 염산염의 제조방법
ITMI20022534A1 (it) * 2002-11-29 2004-05-30 Dinamite Dipharma S P A Procedimento per la preparazione di terbinafina mediante l'uso di platino come catalizzatore.
US20060004230A1 (en) * 2004-06-30 2006-01-05 Joseph Kaspi Process for the preparation of terbinafine and salts thereof

Also Published As

Publication number Publication date
NO20061404L (no) 2006-08-25
MY149357A (en) 2013-08-30
TWI350829B (en) 2011-10-21
WO2005021483A2 (en) 2005-03-10
NZ545445A (en) 2010-03-26
JP5208416B2 (ja) 2013-06-12
ZA200601264B (en) 2007-06-27
PE20050873A1 (es) 2005-11-21
CA2536498C (en) 2012-10-09
AU2004268051B2 (en) 2009-03-05
RU2006109640A (ru) 2007-10-10
US20060076227A1 (en) 2006-04-13
WO2005021483A3 (en) 2005-05-12
US20090216047A1 (en) 2009-08-27
AR045506A1 (es) 2005-11-02
IS8369A (is) 2006-03-23
RU2367649C2 (ru) 2009-09-20
KR20120054109A (ko) 2012-05-29
KR101233024B1 (ko) 2013-02-13
CA2536498A1 (en) 2005-03-10
US7985323B2 (en) 2011-07-26
EP1694631A2 (en) 2006-08-30
JP2007504110A (ja) 2007-03-01
CN100491334C (zh) 2009-05-27
MA28030A1 (fr) 2006-07-03
TNSN06066A1 (en) 2007-10-03
SG145782A1 (en) 2008-09-29
MXPA06002348A (es) 2006-05-22
AU2004268051A1 (en) 2005-03-10
BRPI0413896A (pt) 2006-10-24
GB0320312D0 (en) 2003-10-01
IL173709A0 (en) 2006-07-05
KR20060119892A (ko) 2006-11-24
CN1845895A (zh) 2006-10-11
IL173709A (en) 2012-02-29
TW200523231A (en) 2005-07-16

Similar Documents

Publication Publication Date Title
SE0301009D0 (sv) Novel compounds
NL300933I2 (nl) Letermovir
MXPA03011972A (es) Arilaminas para tratamiento de condiciones asociadas con gsk-3.
CR8975A (es) Proceso para la produccion de derivados de amina opticamente activos
MXPA05008368A (es) 1,2,4-triazinas inhibidoras del virus de inmunodeficiencia humana.
WO2006099941A8 (de) Aminocarbonyl substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
MY139303A (en) Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
CY1110812T1 (el) Παραγωγα διφαινυλοξυοξικου οξεος για τη θεραπεια αναπνευστικων διαταραχων
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
UA83233C2 (ru) Замещенный 2-аминотетралин для лечения депрессии
ATE547417T1 (de) Dihydropyrimidinverbindungen und ihre verwendungen bei der herstellung von medikamenten zur behandlung und prävention antiviraler krankheiten
BRPI0411294A (pt) derivados de amino-propanol
JO2493B1 (en) New phenyl azatidinone with improved physical properties and methods of preparation of drugs containing it and its uses
UY31460A1 (es) Procedimiento de preparacion de compuestos morfinicos
BR0012631A (pt) Processo para a preparação de compostos de amina
ATE424195T1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
AR045506A1 (es) Procedimiento de purificacion de terbinafina por destilacion.
MX2007010403A (es) Proceso de purificacion.
EP1571144A4 (en) HYDROXYALKYLATED CYCLIC DEDIAMINE COMPOUND
MXPA05007315A (es) Sintesis de (r) y (s)-aminocarnitina y derivados de esta de acido d- y l-aspartico.
MA27649A1 (fr) Derives d'acylphenyluree substitues par carbonylamino, methode de production et d'utilisation de ceux-ci.
WO2006138132A3 (en) Commercial adma products having reduced salts and odor and the novel process for preparing same
ITTO20030474A1 (it) Procedimento per la preparazione di dexloxiglumide
MX2007010841A (es) 8-pirrolidinobenzimidazoles biciclicos sustituidos, un metodo para su produccion y su uso como medicamentos.
FR2922207B1 (fr) Procede de purification d'hexamethylene diamine